List view / Grid view

Stefanie Flückiger-Mangual (TOLREMO Therapeutics)

 

article

Women in Stem with Stefanie Flückiger-Mangual

Stefanie Flückiger-Mangual, Chief Executive Officer, is one of TOLREMO’s scientific…

6 May 2024 | By

Stefanie Flückiger-Mangual, Chief Executive Officer, is one of TOLREMO’s scientific founders and an expert in drug resistance in cancer therapy. She is a biomedical scientist and biochemist by training (University of Fribourg and ETH Zurich, Switzerland) and holds a PhD in Molecular and Translational Biomedicine from ETH Zurich. She led…